181 related articles for article (PubMed ID: 3913270)
1. [Acceptability, compliance and tolerance of daily polychemotherapy by leprosy patients in Guadeloupe].
Cartel JL; Gallais JJ; Grosset JH
Acta Leprol; 1985; 3(4):339-55. PubMed ID: 3913270
[TBL] [Abstract][Full Text] [Related]
2. [5-year assessment of daily multi-drug therapy of leprosy in Guadeloupe since 1980].
Cartel JC; Gallais JJ; Naudillon Y; Millan J; Grosset JH
Acta Leprol; 1986; 4(4):415-25. PubMed ID: 3296612
[TBL] [Abstract][Full Text] [Related]
3. [Combination drug therapy in leprosy].
Terencio de las Aguas J
Acta Leprol; 1983; 1(3):143-50. PubMed ID: 6359802
[TBL] [Abstract][Full Text] [Related]
4. [A trial of polychemotherapy of leprosy in the Dakar region. Initial observations on the acceptability of the protocols used].
Millan J; Bodian M; Naudin JC; Diouf B; Boucher P; Ndoye B; Grosset J
Acta Leprol; 1986; 4(1):19-35. PubMed ID: 3526792
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
Winsley BE; McDougall AC; Brown KE
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974
[No Abstract] [Full Text] [Related]
6. Hepatitis in leprosy patients treated by a daily combination of dapsone, rifampin, and a thioamide.
Cartel JL; Millan J; Guelpa-Lauras CC; Grosset JH
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):461-5. PubMed ID: 6686970
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of multidrug therapy (MDT) in Hansen's disease in an urban population--Curupaiti State Hospital, Rio de Janeiro, Brazil.
Andrade VL; Marques AB; da Cunha LH; Avelleira JR
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):435-40. PubMed ID: 3655459
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation 7 to 9 years later of trials of polychemotherapy carried out in Senegal in patients with leprosy].
Millan J; Faure I; Diouf B; Languillon J
Acta Leprol; 1985; 3(2):95-102. PubMed ID: 3907256
[No Abstract] [Full Text] [Related]
9. Late reversal reaction after combined treatment of a patient with multibacillary leprosy.
Pattyn SR; Eyckmans L; Gigase P
Ann Soc Belg Med Trop; 1984 Sep; 64(3):291-4. PubMed ID: 6508392
[No Abstract] [Full Text] [Related]
10. Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):536-41. PubMed ID: 1299708
[TBL] [Abstract][Full Text] [Related]
11. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
12. Combined treatment for lepromatous leprosy.
Ellard GA
Lepr Rev; 1980 Sep; 51(3):199-205. PubMed ID: 6160365
[No Abstract] [Full Text] [Related]
13. The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.
Chum HJ
Lepr Rev; 1986; 57 Suppl 3():63-6. PubMed ID: 3573963
[No Abstract] [Full Text] [Related]
14. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
15. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
[TBL] [Abstract][Full Text] [Related]
16. Hepatotoxicity of the combination of rifampin-ethionamide in the treatment of multibacillary leprosy.
Pattyn SR; Janssens L; Bourland J; Saylan T; Davies EM; Grillone S; Feracci C
Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):1-6. PubMed ID: 6368424
[TBL] [Abstract][Full Text] [Related]
17. The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
Depasquale G
Lepr Rev; 1986; 57 Suppl 3():29-37. PubMed ID: 3573957
[No Abstract] [Full Text] [Related]
18. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity of the daily combination of 5 mg/kg prothionamide + 10 mg/kg rifampin.
Cartel JL; Naudillon Y; Artus JC; Grosset JH
Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):15-8. PubMed ID: 3998559
[TBL] [Abstract][Full Text] [Related]
20. Comparison of DDS with two combined chemotherapy regimens for multibacillary leprosy. Results after 3 years of treatment. A prospective randomized multicentre study.
Dietrich M; Wabitsch R
Lepr Rev; 1986; 57 Suppl 3():60-2. PubMed ID: 3573962
[No Abstract] [Full Text] [Related]
[Next] [New Search]
